Here are the top 5 posts this month.

New use of old drug: Sildenafil Citrate (Viagra) improves amniotic fluid index in oligohydramnios.

Sildenafil Citrate (Viagra) improves amniotic fluid index in pregnancies complicated by oligohydramnios according to a new study published ahead of print on March 6,2017 in Journal of Obstetrics and Gynecology. [1]

https://obgynupdated.blogspot.com/2017/03/new-use-of-old-drug-sildenafil-citrate.html

ACOG releases recommendations for management of acute onset, severe hypertension in pregnancy and postpartum period.

It is estimated that ten million women develop preeclampsia each year around the world, with 76,000 deaths due preeclampsia and related hypertensive disorders.  It is also responsible for 50,000 stillbirths and early neonatal deaths in developing nations.

ACOG committee opinion was published online ahead of print in Journal of Obstetrics and Gynecology.

https://obgynupdated.blogspot.com/2017/03/acog-releases-recommendations-for.html

New Single Handed IUD Inserter for LILETTA released easing IUD insertion.

Allergan a leading global pharmaceutical company, and Medicines360, a nonprofit global women's health pharmaceutical company, recently launched the new LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg IUD single-handed inserter (intrauterine device), for use by women to prevent pregnancy for up to three years. The system needs to be replaced after 3 years if continuous protection is desired. 

https://obgynupdated.blogspot.com/2017/03/new-single-handed-iud-inserter-for.html

Ethicon ENSEAL® X1 Large Jaw Tissue Sealer gets FDA approval: Excellent for performing abdominal and vaginal hysterectomies.

Ethicon, today announced the release of its new ENSEAL X1 Large Jaw Tissue Sealer. Designed for use in open surgeries it is an advanced bipolar device that provides less blood loss, less thermal spread, and improved ergonomics compared to as compared to Medtronic’s LigaSure Impact™.

https://obgynupdated.blogspot.com/2017/03/ethicon-enseal-x1-large-jaw-tissue.html

ASCO issues first global resource stratified guidelines for HPV vaccination for the prevention of cervical cancer.

ASCO today issued first guidelines on primary prevention of cervical cancer that can be used by physicians around the globe as it is tailored according to region, social and economic settings and healthcare resources available. The guidelines were published online in Journal of Global Oncology. [1]

The guidelines offer four levels of recommendations: basic, limited, enhanced and maximal based on the country’s healthcare circumstances and were developed by experts from multiple disciplines representing various countries across the globe.

https://obgynupdated.blogspot.com/2017/03/asco-issues-first-global-resource.html

Here are the top 5 posts this week.

New use of old drug: Sildenafil Citrate (Viagra) improves amniotic fluid index in oligohydramnios.

Sildenafil Citrate (Viagra) improves amniotic fluid index in pregnancies complicated by oligohydramnios according to a new study published ahead of print on March 6,2017 in Journal of Obstetrics and Gynecology.

Link to the article: https://obgynupdated.blogspot.com/2017/03/new-use-of-old-drug-sildenafil-citrate.html

Ethicon ENSEAL® X1 Large Jaw Tissue Sealer gets FDA approval: Excellent for performing abdominal and vaginal hysterectomies.

Ethicon, today announced the release of its new ENSEAL X1 Large Jaw Tissue Sealer. Designed for use in open surgeries it is an advanced bipolar device that provides less blood loss, less thermal spread, and improved ergonomics compared to as compared to Medtronic’s LigaSure Impact™.

Link to the article: https://obgynupdated.blogspot.com/2017/03/ethicon-enseal-x1-large-jaw-tissue.html

Trichomonas vaginalis Infection: Is it time to reconsider the single dose treatment?

Women receiving the recommended single dose therapy for Trichomonas vaginalis are 1.8 times more likely to have relapse of infection as compared to women receiving multi dose treatment says results of a recent Meta-analysis published in Journal of American Sexually Transmitted Disease Association.

Link to the article: https://obgynupdated.blogspot.com/2017/03/trichomonas-vaginalis-infection-is-it.html

FDA approves Noctiva, the first treatment for frequent nighttime urination.

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who have to go for urination at least two times per night, a condition known as nocturnal polyuria. [1]

Noctiva is the first FDA-approved treatment for this condition. About 200 million people worldwide suffer from nocturia.

Link to the article: https://obgynupdated.blogspot.com/2017/03/fda-approves-noctiva-first-treatment.html

Biodegradable sanitary napkins from banana plant: a step towards revolutionizing feminine hygiene in India.

A new healthcare start-up founded by three Massachusetts Institute of Technology graduates have launched a new revolution in women’s hygiene industry by creating biodegradable sanitary napkins from locally sourced banana fibers. They are also hoping to improve waste disposal of pads because it degrades faster if buried. On average, a single woman generates 125 kg of sanitary waste during her menstruating years when she uses disposable sanitary products. [2]

Link to the article: https://obgynupdated.blogspot.com/2017/03/biodegradable-sanitary-napkins-from.html